{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:44:21Z","timestamp":1791935061047,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T00:00:00Z","timestamp":1708819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1020327"],"award-info":[{"award-number":["OPP1020327"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.02.066","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T09:48:05Z","timestamp":1710409685000},"page":"2680-2686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys"],"prefix":"10.1016","volume":"42","author":[{"given":"Grant A","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Salaudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Badji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Manjang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-7186","authenticated-orcid":false,"given":"Effua","family":"Usuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-8412","authenticated-orcid":false,"given":"Christian","family":"Bottomley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2024.02.066_b0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciw720","article-title":"Long-term impact of a \u201c3 + 0\u201d schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002\u20132014","volume":"64","author":"Jayasinghe","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.066_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.066_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.066_b0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in the Gambia: a population-based surveillance study","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.066_b0025","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(20)30880-X","article-title":"Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in the Gambia: 10 years of population-based surveillance","volume":"21","author":"Mackenzie","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10186","key":"10.1016\/j.vaccine.2024.02.066_b0030","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0140-6736(18)33005-8","article-title":"Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study","volume":"393","author":"Hammitt","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.066_b0035","doi-asserted-by":"crossref","first-page":"e0195799","DOI":"10.1371\/journal.pone.0195799","article-title":"Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England","volume":"13","author":"Southern","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.066_b0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"issue":"38","key":"10.1016\/j.vaccine.2024.02.066_b0045","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Sweden Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.066_b0050","article-title":"Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after ten years of pneumococcal conjugate vaccine pressure","author":"Usuf","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.066_b0055","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/cid\/ciy726","article-title":"Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of nonvaccine serotypes among vaccinated infants and their mothers 5 years after introduction of pneumococcal conjugate vaccine 13 in the Gambia","volume":"68","author":"Usuf","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.066_b0060","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.066_b0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/CVI.00435-09","article-title":"Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway","volume":"17","author":"Vestrheim","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.066_b0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/EDE.0b013e3182087634","article-title":"Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations","volume":"22","author":"Weinberger","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2024.02.066_b0075","doi-asserted-by":"crossref","unstructured":"Kabore L, Adebanjo T, Njanpop-Lafourcade BM, et al. Pneumococcal carriage in Burkina Faso after 13-valent pneumococcal conjugate vaccine introduction: results from two cross-sectional population-based surveys. J Infect Dis 2021 Sep 1;224(12 Suppl 2):S258-S266.","DOI":"10.1093\/infdis\/jiab037"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.066_b0080","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/cid\/ciab645","article-title":"Dynamics of invasive pneumococcal disease in Israel in children and adults in the 13-valent pneumococcal conjugate vaccine (PCV13) era: a Nationwide prospective surveillance","volume":"74","author":"Ben-Shimol","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.066_b0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/tmi.12505","article-title":"Pneumococcal carriage in rural Gambia prior to the introduction of pneumococcal conjugate vaccine: a population-based survey","volume":"20","author":"Usuf","year":"2015","journal-title":"Trop Med Int Health"},{"issue":"9465","key":"10.1016\/j.vaccine.2024.02.066_b0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.066_b0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"issue":"6680","key":"10.1016\/j.vaccine.2024.02.066_b0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.298.6680.1061","article-title":"Latex agglutination test for diagnosing pneumococcal pneumonia in children in developing countries","volume":"298","author":"O'Neill","year":"1989","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.066_b0105","first-page":"699","article-title":"The quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.vaccine.2024.02.066_b0110","doi-asserted-by":"crossref","unstructured":"Quesada MG, PSERENADE. Serotype distribution by age of remaining invasive pneumococcal disease after long-term PCV10\/13 use. Open Forum Infectious Diseases 2021 Dec 4;8(Supplement 1):S683-S684.","DOI":"10.1093\/ofid\/ofab466.1374"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.066_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"16","key":"10.1016\/j.vaccine.2024.02.066_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12874-016-0127-1","article-title":"Can the buck always be passed to the highest level of clustering?","volume":"8","author":"Bottomley","year":"2016","journal-title":"BMC Med Res Methodol"},{"issue":"89","key":"10.1016\/j.vaccine.2024.02.066_b0125","doi-asserted-by":"crossref","first-page":"20130786","DOI":"10.1098\/rsif.2013.0786","article-title":"A mathematical model of serotype replacement in pneumococcal carriage following vaccination","volume":"10","author":"Bottomley","year":"2013","journal-title":"J R Soc Interface"},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.066_b0130","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.066_b0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jpids\/piaa132","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae nasopharyngeal carriage among children less than 5 years old: 3 years post-10-valent pneumococcal conjugate vaccine introduction in Mozambique","volume":"10","author":"Valenciano","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.066_b0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14760584.2020.1750377","article-title":"Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization","volume":"19","author":"Madhi","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.066_b0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12916-019-1450-2","article-title":"Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study","volume":"17","author":"Lourenco","year":"2019","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.066_b0150","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S1473-3099(22)00438-8","article-title":"Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study","volume":"22","author":"Swarthout","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.066_b0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.epidem.2010.03.005","article-title":"Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete","volume":"2","author":"Hanage","year":"2010","journal-title":"Epidemics"},{"key":"10.1016\/j.vaccine.2024.02.066_b0160","doi-asserted-by":"crossref","unstructured":"Abdullahi O, Karani A, Tigoi CC, et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis 2012 Oct 1;206:1020-29.","DOI":"10.1093\/infdis\/jis447"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.066_b0165","doi-asserted-by":"crossref","first-page":"e1001107","DOI":"10.1371\/journal.pmed.1001107","article-title":"Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial","volume":"8","author":"Roca","year":"2011","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.066_b0170","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T06:05:18Z","timestamp":1712124318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24002251"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}